Correlation Between OmniAb and Kronos Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OmniAb and Kronos Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OmniAb and Kronos Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OmniAb Inc and Kronos Bio, you can compare the effects of market volatilities on OmniAb and Kronos Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OmniAb with a short position of Kronos Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of OmniAb and Kronos Bio.

Diversification Opportunities for OmniAb and Kronos Bio

0.01
  Correlation Coefficient

Significant diversification

The 3 months correlation between OmniAb and Kronos is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding OmniAb Inc and Kronos Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kronos Bio and OmniAb is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OmniAb Inc are associated (or correlated) with Kronos Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kronos Bio has no effect on the direction of OmniAb i.e., OmniAb and Kronos Bio go up and down completely randomly.

Pair Corralation between OmniAb and Kronos Bio

Given the investment horizon of 90 days OmniAb Inc is expected to generate 0.56 times more return on investment than Kronos Bio. However, OmniAb Inc is 1.78 times less risky than Kronos Bio. It trades about 0.02 of its potential returns per unit of risk. Kronos Bio is currently generating about 0.01 per unit of risk. If you would invest  371.00  in OmniAb Inc on September 16, 2024 and sell it today you would earn a total of  8.00  from holding OmniAb Inc or generate 2.16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

OmniAb Inc  vs.  Kronos Bio

 Performance 
       Timeline  
OmniAb Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OmniAb Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's fundamental drivers remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Kronos Bio 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Kronos Bio are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Kronos Bio may actually be approaching a critical reversion point that can send shares even higher in January 2025.

OmniAb and Kronos Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OmniAb and Kronos Bio

The main advantage of trading using opposite OmniAb and Kronos Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OmniAb position performs unexpectedly, Kronos Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kronos Bio will offset losses from the drop in Kronos Bio's long position.
The idea behind OmniAb Inc and Kronos Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance